Richard Kovach, MD
Cardiovascular Disease · Browns Mills, NJNPI 1144209891
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (48.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 48.6% of the total. Reporting peaked in 2021 at $157,026 and has fallen 85.2% since, to $23,186 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 520 payments — averaging $577.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$146K
- Shockwave Medical, Inc$52K
- Philips North America LLC$24K
- Boston Scientific$20K
- Abbott$13K
- Siemens Medical Solutions USA, Inc.$12K
- plus $33K from 27 others
Across 111 payments — averaging $1453.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$119K
- Abbott$39K
- Philips North America LLC$900
- Bard Peripheral Vascular, Inc.$700
- Cordis Corporation$600
- Intact Vascular, Inc.$600
- plus $700 from 2 others
Across 7 payments — averaging $54.29 each. An ownership or investment interest held by the physician or an immediate family member.
- Verge Medical, Inc.$380
What the payments were for
- Consulting fees$49,56517%
- Speaking & faculty fees$57,70019%
- Travel & lodging$22,8388%
- Food & beverage$24,3438%
- Other$145,93649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 3 | $146,072 |
| Shockwave Medical, Inc | 74 | $51,528 |
| Philips North America LLC | 35 | $24,451 |
| Boston Scientific | 104 | $20,320 |
| Abbott | 58 | $13,206 |
| Siemens Medical Solutions USA, Inc. | 22 | $11,988 |
| Venturemed Group, Inc. | 11 | $7,636 |
| Medtronic(2 entities) | 32 | $7,557 |
| Edwards Lifesciences | 26 | $3,858 |
| Abiomed | 61 | $3,006 |
| Cardiovascular Systems Inc. | 20 | $2,347 |
| Ancora Heart, Inc. | 10 | $1,964 |
| Endologix LLC | 4 | $1,881 |
| Penumbra, Inc. | 10 | $860 |
| Saranas, Inc. | 10 | $657 |
| Terumo Medical Corporation | 1 | $450 |
| Inari Medical, Inc. | 6 | $426 |
| Angiodynamics, Inc. | 5 | $328 |
| Cardiac Dimensions, Inc. | 4 | $291 |
| Johnson & Johnson | 3 | $246 |
| Biotronik Inc. | 4 | $220 |
| W. L. Gore & Associates, Inc. | 2 | $193 |
| Cagent Vascular Inc | 2 | $172 |
| Surmodics, Inc. | 1 | $136 |
| Teleflex LLC | 3 | $123 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| AstraZeneca | 1 | $96 |
| Boehringer Ingelheim | 1 | $79 |
| Cvrx, Inc. | 2 | $68 |
| Nipro Medical Corporation | 1 | $40 |
| Cardinal Health 200 LLC | 1 | $33 |
| Avinger Inc. | 1 | $25 |
| Veryan Medical Incorporated | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$50,743
- US Und$15,000
- Omnilink Elite vascular stent system$6,400
- FLEX Scoring Catheter$5,797
- GENERAL - THERAPIES$4,396
- GENERAL VASCULAR ACCESS$4,339
- Spectranetics Undiv$4,000
- GENERAL - STRUCTURAL HEART$4,000
- HawkOne$3,000
- (9520) IGT Devices Undivided$2,658
- CoreValve Evolut$2,621
- Diamondback Peripheral$1,966
- Diamondback Coronary$1,966
- AccuCinch$1,860
- Impella$1,806
- Xience V coronary stent system$1,733
- Torus Stent Graft System$1,650
- ENDOCROSS Device$1,650
- FLEX Vessel Prep System$1,600
- PASCAL$1,554
How this compares
$300,382 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 14 | $8,454 |
| EliquisApixaban | 13 | $7,840 |
| ClopidogrelClopidogrel Bisulfate | 17 | $326 |
| Atorvastatin Calcium | 13 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $96 | $8,45414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in Browns Mills
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
- Fadi ChaabanWest Orange$161K
- Muhamed SaricNewark$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.